![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
10 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
AACR: Lung Cancer Therapy Innovations Cancer Network Podcasts
-
- Science
In this interview, ahead of the AACR annual meeting, we speak with Dr. Julie Brahmer, of Johns Hopkins School of Medicine, who is giving a presentation on immunotherapy in lung cancer, and is one of the clinical investigators of the extensive phase I trial of the anti–PD-1 antibody nivolumab.
In this interview, ahead of the AACR annual meeting, we speak with Dr. Julie Brahmer, of Johns Hopkins School of Medicine, who is giving a presentation on immunotherapy in lung cancer, and is one of the clinical investigators of the extensive phase I trial of the anti–PD-1 antibody nivolumab.
10 min